The Pharmaceutical Cold Chain Packaging Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The market size of the pharmaceutical cold chain packaging has been expanding quickly in the recent past. The market, which was worth $23.44 billion in 2024, is projected to reach $27.14 billion in 2025. This implies a compound annual growth rate (CAGR) of 15.8%.
The pharmaceutical cold chain packaging market is forecasted to reach $48.34 billion in market size by 2029, with a compound annual growth rate (CAGR) of 15.5%.
Download Your Free Sample of the 2025 Pharmaceutical Cold Chain Packaging Market Report and Uncover Key Trends Now!The key drivers in the pharmaceutical cold chain packaging market are:
• Rising demand for biologics and vaccines due to prevalence of chronic diseases
• Increasing need for advanced therapies for diseases like cancer and diabetes
• Critical role of cold chain packaging in preserving the stability, potency, and safety of biologics and vaccines
• Growing coverage and distribution of vaccines across different regions
The pharmaceutical cold chain packaging market covered in this report is segmented –
1) By Product Type: Insulated Shippers, Insulated Containers, Gel Packs And Ice Packs, Phase Change Materials, Dry Ice
2) By Packaging Format: Active Packaging, Passive Packaging
3) By Distribution Channel: Direct Sales, Distributors, Online Sales, Retail Pharmacies, Cold Chain Logistics Providers
4) By Application: Vaccines, Biologics, Pharmaceuticals, Clinical Trials, Laboratory Samples
5) By End Use: Biopharmaceutical Companies, Clinical Research Organizations, Hospitals, Research Institutes, Logistics And Distribution Companies, Other End Uses
The key trends in the pharmaceutical cold chain packaging market are:
• Eco-friendly temperature-controlled packaging solutions have become an important trend in the pharmaceutical cold chain packaging market.
• There's a focus on the development of sustainable systems that utilize recyclable, biodegradable, or reusable materials while retaining desired temperature levels of pharmaceutical products.
• Another emerging trend is the use of technology, such as computer-based parametric algorithms, to optimize packaging dimensions, insulation, and coolant requirements - maximising product temperature stability for extended periods.
• Emphasis on the efficient and sustainable aspects of the product, such as flat-pack shipping, is also a crucial emerging trend.
Major players in the pharmaceutical cold chain packaging market are:
• Sonoco Products Company
• Sealed Air Corporation
• Biobase Group
• Csafe Global LLC
• Cryoport Systems LLC
• Cold Chain Technologies LLC
• Topa Thermal BV
• Envirotainer AB
• Haier Biomedical Co. Ltd.
• Peli BioThermal Limited
• SkyCell AG
• Cryopak Industries Inc.
• Sofrigam SAS
• Intelsius LLC
• Softbox Systems Ltd.
• Inmark Global Holdings LLC
• Insulated Products Corporation
• Chill-Pak
• CoolPac Pty Ltd
• Practical Packaging Solutions Inc.
• The Wool Packaging Solutions Limited
• Thermal Energy Service Solutions Pvt. Ltd.
• Thermal Packaging Solutions Ltd.
North America was the largest region in the pharmaceutical cold chain packaging market in 2024